ALAlexey A. Ladutko

Alexey A. Ladutko

*This is an algorithmically generated author record based on publicly available information.

Alexey A. Ladutko has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Intrapleural infusion of ropivacaine in cardiac surgery: protocol for a multicenter randomized double-blind placebo-controlled trial

    by Sergei M. Efremov, N. S. Popkov, E. A. Kokarev, V. A. Sidorenko, A. A. Shadura, D. V. Shmatov, A. A. Ladutko, D. V. Morozovsky

    INTRODUCTION: Effective analgesia is crucial for postoperative management in cardiac surgery patients, impacting both short- and long-term clinical outcomes and quality of life. Pain from pleural drains may be alleviated by intrapleural administration of local anesthetics; however, the effectiveness of this technique has not been confirmed in controlled trials. OBJECTIVE: To test the hypothesis that, in cardiac surgery patients, postoperative recovery quality after anesthesia is improved with intrapleural ropivacaine administration compared to placebo. MATERIALS AND METHODS: This multicenter, double-blind, placebo-controlled trial will randomize 116 patients in a 1 : 1 ratio to receive either intrapleural infusion of 0.25 % ropivacaine solution or placebo. The study will include patients over 18 years scheduled for cardiac surgery via standard median sternotomy with planned pleural cavity opening, who have provided written informed consent. Exclusion criteria include contraindications to ropivacaine and repeat cardiac surgery. RESULTS: The primary endpoint is the Quality of Recovery-15 (QoR15) score on postoperative day 1. Secondary endpoints include the PaO2/FiO2 ratio, opioid analgesic requirements, pain intensity, length of hospital stay, postoperative sternal wound dehiscence, and in-hospital mortality. CONCLUSIONS: This study will be the first to evaluate the efficacy of intrapleural analgesia in relation to QoR15 following cardiac surgery.

  • Open Access

    Effects of intracuff and intravenous lignocaine on recovery from anaesthesia after thyroid surgery. A single-centre randomised double-blind placebo-controlled trial (The IOLANT study)

    by Sergey M. Efremov, Alexey Y. Kulikov, Valeria P. Govorushkina, Daniil D. Sidorov, Alexey A. Ladutko, Oleg V. Kuleshov

    Background and Aims: Despite evidence that local intracuff alkalinised lignocaine may reduce the incidence of exaggerated laryngeal reflexes after thyroid surgery, its effects on the quality of recovery (QoR) from anaesthesia remain unknown. This study aimed to test if local intracuff alkalinised lignocaine improves the QoR from anaesthesia after thyroid surgery compared to placebo. Methods: Patients over 45 years old scheduled for thyroid surgery with electromyographic monitoring under general anaesthesia were enroled in a randomised, single-centre, double-blind, placebo-controlled trial. They were randomised into three groups (1:1:1 ratio): intravenous lignocaine (IVL), topical and intracuff lignocaine (TL), and placebo. The sample size was initially set at 231, but the study was terminated early after an interim analysis of 110 patients showed no significant difference between groups. The primary outcome was the QoR-40 score 24 hours post-surgery. Secondary outcomes included rates of arterial hypotension, coughing during emergence, bispectral index (BIS) values, and electromyographic monitoring characteristics. Results: An interim analysis after 110 patients showed mean QoR-40 scores of 185 (standard deviation(SD): 11.4) (placebo), 186.1 (SD: 13.6) (IVL), and 185.1 (SD: 14.3) (TL) ( P = 0.662). Mean differences were 1.1 (IVL vs placebo, 95%CI: −5.03, 7.15, z = 0.347) and 0.1 (TL vs placebo, 95%CI: −6.02, 6.23, z = 0.035). The study was stopped due to lack of effectiveness as the superiority of IVL and TL was not demonstrated. No differences were found in secondary outcomes. Conclusion: Neither IVL nor TL improved the QoR from anaesthesia and did not affect electromyographic monitoring in low-risk thyroid surgery.